Research and analysis

NERVTAG: Duration of infectiousness following symptoms onset in COVID-19, 13 April 2020

Paper prepared by the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) for the Scientific Advisory Group for Emergencies (SAGE).

• From: Scientific Advisory Group for Emergencies
• Published: 5 June 2020
• Last updated: 30 November 2021 — See all updates

Documents

NERVTAG paper: Duration of infectiousness following symptoms onset in COVID-19, 13 April 2020

PDF, 145 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

NERVTAG: Duration of infectiousness following symptoms onset in COVID-19, 13 April 2020

HTML

Details

Paper by NERVTAG on the duration of infectiousness following symptoms onset in COVID-19. It was considered at SAGE 25 on 14 April 2020.

It should be viewed in context: the paper was the best assessment of the evidence at the time of writing. The picture is developing rapidly and, as new evidence or data emerges, SAGE updates its advice accordingly.

Therefore, some of the information in this paper may have been superseded and the author’s opinion or conclusion may since have developed.

These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.

Published 5 June 2020
Last updated 30 November 2021 + show all updates

1. 30 November 2021

   Added HTML for accessibility.

2. 5 June 2020

   First published.